ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
63,318.76
-0.90%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Magenta Therapeutics Inc (MGTA)

  7. Magenta Therapeutics Inc (MGTA) Noticias

MGTA Magenta Therapeutics Inc

11.1936
0.00 (0.00%)
02 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Magenta Therapeutics Inc MGTA NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 11.1936 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
11.1936 11.1936
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
11/4/202415:10EDGAR2Form ARS - Annual Report to Security Holders
11/4/202415:09EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/4/202415:05EDGAR2Form DEF 14A - Other definitive proxy statements
01/4/202417:34EDGAR2Form SC 13D/A - General statement of acquisition of..
01/4/202417:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/3/202416:10EDGAR2Form S-8 - Securities to be offered to employees in employee..
21/3/202416:02EDGAR2Form S-1/A - General form for registration of securities..
21/3/202415:07EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
21/3/202415:04EDGAR2Form 8-K - Current report
14/2/202415:16EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/2/202415:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/2/202415:52EDGAR2Form S-1/A - General form for registration of securities..
02/2/202415:32EDGAR2Form SC 13G - Statement of acquisition of beneficial..
31/1/202411:11EDGAR2Form SC 13D - General statement of acquisition of beneficial..
26/1/202415:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202415:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202415:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202417:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202416:26EDGAR2Form SC 13D/A - General statement of acquisition of..
22/1/202406:34EDGAR2Form 8-K - Current report
08/1/202407:02EDGAR2Form 8-K - Current report
21/12/202316:08EDGAR2Form S-1/A - General form for registration of securities..
21/12/202315:16EDGAR2Form 8-K - Current report
09/11/202315:09EDGAR2Form 8-K - Current report
25/10/202315:15EDGAR2Form 8-K - Current report
04/10/202315:55EDGAR2Form S-8 - Securities to be offered to employees in employee..
04/10/202315:20EDGAR2Form S-3 - Registration statement under Securities Act of..
25/9/202315:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202315:34EDGAR2Form SC 13D - General statement of acquisition of beneficial..
21/9/202315:32EDGAR2Form SC 13D - General statement of acquisition of beneficial..
21/9/202315:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
21/9/202315:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
20/9/202320:50EDGAR2Form 8-K/A - Current report: [Amend]
13/9/202320:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202320:31EDGAR2Form 3 - Initial statement of beneficial ownership of..
13/9/202320:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202320:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202320:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202319:52EDGAR2Form 3 - Initial statement of beneficial ownership of..
13/9/202319:50EDGAR2Form 3 - Initial statement of beneficial ownership of..
13/9/202319:48EDGAR2Form 3 - Initial statement of beneficial ownership of..
13/9/202319:46EDGAR2Form 3 - Initial statement of beneficial ownership of..
13/9/202319:45EDGAR2Form 3 - Initial statement of beneficial ownership of..
12/9/202315:05EDGAR2Form 8-K - Current report
08/9/202316:19EDGAR2Form 8-K - Current report
31/8/202308:00EDGAR2Form 425 - Prospectuses and communications, business..
03/8/202307:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/8/202315:42EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
17/7/202308:30EDGAR2Form S-4/A - Registration of securities, business..

Su Consulta Reciente

NASDAQ
MGTA
Magenta Therapeutics
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados